This phosphorylation inhibits acetyl-CoA carboxylase, which in turn lowers the concentration of malonyl-CoA

Scientific Sessions Endocrine Disorders: Thyroid Disorders Pituitary Disorders Adrenal Disorders Reproductive Endocrinology Metabolic Disorders Diabetes and Metabolic Syndrome: Type 1 Diabetes Type 2 Diabetes Gestational Diabetes Diabetic Complications Obesity and Metabolic Syndrome Cardiovascular Health: Coronary Artery Disease Hypertension Heart Failure Arrhythmias Vascular Diseases Precision Medicine and Personalized Therapies: Genomics and Biomarkers Pharmacogenomics Individualized Treatment Approaches Precision Nutrition Digital Health and Wearable Devices Emerging Technologies and Innovations: Artificial Intelligence in Healthcare Telemedicine and Remote Monitoring Nanotechnology in Endocrine and Cardiovascular Health Novel Drug Delivery Systems Regenerative Medicine Lifestyle Interventions and Patient Empowerment: Nutrition and Dietetics Exercise and Physical Activity Behavioral Interventions Patient Education and Self-Management Integrative Medicine Approaches Clinical Research and Translational Science: Clinical Trials and Study Design Translational Research in Endocrinology, Diabetes & Cardiovascular Health Data Analytics and Big Data in Healthcare Health Outcomes and Health Economics Quality Improvement Initiatives Healthcare Policy and Public Health: Healthcare Systems and Policies Prevention and Health Promotion Strategies Global Health Perspectives Health Disparities and Equity Community Engagement and Advocacy Target Audience The World Endocrine, Diabetes & Cardiovascular Conference 2026 (EDCC26) is designed for a diverse range of healthcare professionals, researchers, academicians, and industry experts who are involved in or have a keen interest in the fields of endocrinology, diabetes, and cardiovascular health

Oral Supplements IV therapy offers significant advantages over traditional oral supplementation: Absorption 100% vs
Healthy routines and habits include following a diet rich in whole, vitamin-rich foods, staying hydrated throughout the day, maintaining a consistent and restorative sleep schedule, and avoiding unhealthy substances like alcohol and processed foods
Yes, short-acting GLP-1 medications like exenatide (Byetta) with a 2.4-hour half-life clear within 1224 hours, while long-acting formulations can take 410 weeks to fully eliminate